Malady Kyle โ EVP and Group CEO-VZ Business
Shares
135
Price
$12.91
Total Value
$1,738.41
Nearby Earnings
Oct 20, 2026
EPS:Est: 1.28
Revenue:Est: $34.79B
Oct 26, 2026
EPS:1.31 (est: 1.27)+3.1%
Revenue:$34.31B (est: $34.77B)-1.3%
Nov 4, 2026
EPS:Est: 1.28
Revenue:Est: $34.78B
Transaction Details
| Insider | Malady Kyle |
|---|---|
| Title | EVP and Group CEO-VZ Business |
| Transaction Date | Oct 22, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Phantom Stock (unitized) |
| Derivative | Yes |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Deferred Compensation Plan |
| Filing Date | Oct 23, 2026 |
| Shares Purchased | 135 |
| Price per Share | $12.91 |
| Total Value | $1,738.41 |
| Shares Owned After | 424,778 |
| Derivative | Derivative |
| Accession Number | 0001760581-26-000073 |
| Document | View SEC Filing |